Neuropathological spectrum of synucleinopathies

Area of Science:

• Neurology
• Neuroscience
• Pathology

Background:

• Synucleinopathies are a group of neurodegenerative diseases defined by alpha-synuclein protein aggregates.
• These aggregates form pathological lesions like Lewy bodies and Papp-Lantos filaments, implicated in neuronal and glial degeneration.
• Key synucleinopathies include Lewy body disorders, dementia with Lewy bodies, multiple system atrophy (MSA), and Hallervorden-Spatz disease.

Purpose of the Study:

• To delineate the pathological characteristics and diagnostic criteria for major synucleinopathies.
• To describe the specific alpha-synuclein inclusions in multiple system atrophy and Hallervorden-Spatz disease.
• To explore the potential role and nature of alpha-synuclein aggregation in neurodegeneration.

Main Methods:

• Review of pathological hallmarks and diagnostic criteria for Lewy body disorders.
• Characterization of alpha-synuclein-positive inclusions in multiple system atrophy.
• Examination of alpha-synuclein presence in axonal spheroids in Hallervorden-Spatz disease.
• Analysis of conformational differences in alpha-synuclein aggregates.

Main Results:

• Lewy body disorders and dementia with Lewy bodies are diagnosed by semiquantitative assessment of Lewy bodies.
• Multiple system atrophy features alpha-synuclein-positive glial and neuronal inclusions, linked to specific degeneration patterns.
• Hallervorden-Spatz disease shows alpha-synuclein in axonal spheroids and inclusions.
• Conformational variations exist in alpha-synuclein between neuronal and glial aggregates.

Conclusions:

• The pathway from soluble to aggregated alpha-synuclein is central to synucleinopathy pathogenesis.
• The precise function of inclusion body formation—whether protective or pathogenic—remains unclear.
• Further research is needed to understand the triggers and consequences of alpha-synuclein aggregation in neurodegeneration.